Advertisement

Topics

Bayer nears seven-year low after $2 billion award in Roundup trial

08:22 EDT 14 May 2019 | Reuters

Bayer shares fell by as much as 5 percent on Tuesday after a California couple were awarded more than $2 billion in the largest U.S. jury penalty over allegations its Roundup weed killer causes cancer.

Original Article: Bayer nears seven-year low after $2 billion award in Roundup trial

NEXT ARTICLE

More From BioPortfolio on "Bayer nears seven-year low after $2 billion award in Roundup trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...